Cohen & Steers Q3 2026: EPS $0.81 GAAP / $0.89 Adjusted, AUM $95.9B, $1.6B Net Inflows
CNS sits 18% above its 52-week low of $58.39 on elevated volume (2.1× avg).
Summary
Cohen & Steers reported Q3 2026 GAAP EPS of $0.81 and adjusted EPS of $0.89 on revenue of $157.4M, with AUM falling 4.2% to $95.9B on market depreciation despite $1.6B of net inflows — the strongest since Q4 2021.
Key Events · Earnings and Guidance · CNS
-
Q3 2026 Earnings: EPS $0.81 GAAP / $0.89 Adjusted
GAAP diluted EPS of $0.81 and adjusted EPS of $0.89, down from Q2 2026's $0.95 GAAP / $0.85 adjusted. Revenue rose ~3% sequentially to $157.4M.
-
AUM Falls 4.2% to $95.9B on Market Depreciation
AUM declined from $100.1B at June 30, 2026 to $95.9B at September 30, 2026, driven by $5.1B of market depreciation and $632M of distributions, partially offset by $1.6B of net inflows.
-
Strongest Net Inflows Since Q4 2021
Firmwide net inflows of $1.6B marked the fifth consecutive quarter of organic growth and the strongest quarter since Q4 2021, with positive contributions across all strategies and vehicles.
-
GAAP Margin Compresses to 32.4%; Adjusted Margin Improves to 37.2%
GAAP operating margin fell from 34.6% in Q2 2026 to 32.4%, primarily on higher distribution and service fees from the RQI rights offering. Adjusted operating margin improved to 37.2% from 36.3%.
Analysis · CNS · Finance
Cohen & Steers reported Q3 2026 results with GAAP diluted EPS of $0.81 and adjusted EPS of $0.89, down from Q2's $0.95 GAAP / $0.85 adjusted. Revenue rose ~3% sequentially to $157.4M on higher average AUM, but AUM ended the quarter at $95.9B, down 4.2% from $100.1B, as $5.1B of market depreciation more than offset $1.6B of net inflows. The $1.6B net inflow quarter was the strongest since Q4 2021 and the fifth consecutive quarter of organic growth, with broad-based demand across wealth and institutional channels. GAAP operating margin compressed to 32.4% from 34.6% on higher distribution and service fees tied to the RQI rights offering, while adjusted margin improved to 37.2% from 36.3%. The firm's cash and liquid seed investments grew to $387.8M from $354.3M. The key tension for investors: strong organic growth and record inflows versus market-driven AUM decline and GAAP margin compression.
How filings like this one have moved
In the 30 days to Nov 2, 2026, 32.7% of the 1910 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CNS was trading at $68.98 on NYSE in the Finance sector, with a market capitalization of approximately $3.5B. The 52-week trading range was $58.39 to $86.56. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.